Canton Strategic Holdings, Inc. (CNTN) Income Statement

NASDAQ: CNTNRevenue, profits, margins and EPS over 7 years.

CNTN 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Research & development−51.9%
$3.1M
2025 · hover or tap a bar for each year
2019: $368,7322020: $847,272 (+129.8%)2021: $1.8M (+117.5%)2022: $2.3M (+23.6%)2023: $3.6M (+56.2%)2024: $6.4M (+79.6%)2025: $3.1M (−51.9%)
20192025
Operating expenses+61.7%
$20.1M
2025 · hover or tap a bar for each year
2019: $994,5392020: $1.5M (+52.7%)2021: $3.2M (+111.2%)2022: $6.9M (+114.5%)2023: $9.5M (+37.4%)2024: $12.4M (+31.5%)2025: $20.1M (+61.7%)
20192025
Operating income
−$20.1M
2025 · hover or tap a bar for each year
2019: −$994,5392020: −$1.5M2021: −$3.2M2022: −$6.9M2023: −$9.5M2024: −$12.4M2025: −$20.1M
20192025
Net income
−$35.9M
2025 · hover or tap a bar for each year
2019: −$1.5M2020: −$2.4M2021: −$2.2M2022: −$8.5M2023: −$9.3M2024: −$12.2M2025: −$35.9M
20192025
EPS (diluted)
−$2.76
2025 · hover or tap a bar for each year
2020: −$84.232021: −$72.832022: −$284.102023: −$188.802024: −$9.682025: −$2.76
20192025

CNTN revenue and net income

RevenueNet incomeNet margin (right axis)

CNTN growth rates

to 2025
1 year3 years5 years10 years
Revenue————
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

CNTN quarterly EPS vs estimates

Reported EPSAnalyst estimate

Next report: November 11, 2026.

CNTN income statement

Canton Strategic Holdings, Inc. annual income statement
2025202420232022202120202019
Revenue$0$0$0$0$0$0$0
Research & development$3.1M$6.4M$3.6M$2.3M$1.8M$847,272$368,732
Sales, general & admin$17.0M$6.0M$5.9M$4.6M$1.4M——
Total operating expenses$20.1M$12.4M$9.5M$6.9M$3.2M$1.5M$994,539
Operating income−$20.1M−$12.4M−$9.5M−$6.9M−$3.2M−$1.5M−$994,539
Interest income$41,410$249,908$152,631$0———
Interest expense$28,345$13,684$16,505$1.6M$831,277$246,534$75,074
Income before taxes−$42.1M−$12.2M−$9.3M−$8.5M−$2.2M−$2.4M−$1.5M
Income taxes−$6.2M——————
Net income−$35.9M−$12.2M−$9.3M−$8.5M−$2.2M−$2.4M−$1.5M
EBITDA−$20.1M−$12.2M$152,631−$5.3M−$1.4M−$2.2M−$1.5M
EPS (diluted)−$2.76−$9.68−$188.80−$284.10−$72.83−$84.23—

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CNTN's financial statements (latest annual report filed March 31, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

CNTN financial results

Canton Strategic reported no revenue in fiscal year 2025 (ended December 31, 2025). It had a net loss of $35.9 million. Diluted earnings per share came to −$2.76.

See the CNTN stock overview for the latest quote and news, or the CNTN chart for price history and technical indicators.

CNTN income statement FAQ

Does Canton Strategic have revenue?

Canton Strategic reported no revenue for fiscal year 2025, which ended on December 31, 2025.

Is Canton Strategic profitable?

No. Canton Strategic reported a net loss of $35.9 million in fiscal 2025.

How much does Canton Strategic spend on research and development?

Canton Strategic spent $3.1 million on research and development in fiscal 2025.

What are Canton Strategic's earnings per share?

Canton Strategic earned $-2.76 per diluted share in fiscal 2025, compared with $-9.68 a year earlier.

When will Canton Strategic report its next earnings?

Canton Strategic is expected to report results for the quarter ending September 30, 2026 on November 11, 2026.

When does Canton Strategic's fiscal year end?

Canton Strategic's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 31, 2026.

Biotechnology income statements